Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solut... Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. Show more
Cardiol Therapeutics President and CEO, David Elsley NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView announces the release of an informative interview with Cardiol Therapeutics...
NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView, a leading provider of market insights and company news, proudly announces that Cardiol Therapeutics Inc. (NASDAQ: CRDL, TSX: CRDL...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.09 | -6.56934306569 | 1.37 | 1.4599 | 1.27 | 416220 | 1.33696977 | CS |
4 | -0.37 | -22.4242424242 | 1.65 | 1.67 | 1.27 | 389963 | 1.46188251 | CS |
12 | -0.84 | -39.6226415094 | 2.12 | 2.24 | 1.27 | 489866 | 1.74954547 | CS |
26 | -0.73 | -36.3184079602 | 2.01 | 2.63 | 1.27 | 402749 | 1.90003844 | CS |
52 | 0.42 | 48.8372093023 | 0.86 | 3.12 | 0.7912 | 409171 | 1.90430211 | CS |
156 | -0.72 | -36 | 2 | 3.12 | 0.45 | 274329 | 1.54813993 | CS |
260 | -1.35 | -51.3307984791 | 2.63 | 4.96 | 0.45 | 333652 | 2.03381943 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales